190 related articles for article (PubMed ID: 38231476)
1. Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.
Sasine JP; Kozlova NY; Valicente L; Dukov J; Tran DH; Himburg HA; Kumar S; Khorsandi S; Chan A; Grohe S; Li M; Kan J; Sehl ME; Schiller GJ; Reinhardt B; Singh BK; Ho R; Yue P; Pasquale EB; Chute JP
Cancer Res; 2024 Mar; 84(6):919-934. PubMed ID: 38231476
[TBL] [Abstract][Full Text] [Related]
2. Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions.
Xiong C; Wen Y; Zhao J; Yin D; Xu L; Chelariu-Raicu A; Yao C; Leng X; Liu J; Chaudhari RR; Zhang S; Sood AK; Li C
Sci Rep; 2020 Jan; 10(1):520. PubMed ID: 31949258
[TBL] [Abstract][Full Text] [Related]
3. Generation of transgenic mice overexpressing EfnB2 in endothelial cells.
Luxey M; Laussu J; Jungas T; Davy A
Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
[TBL] [Abstract][Full Text] [Related]
5. Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake.
Xu C; Gu L; Kuerbanjiang M; Jiang C; Hu L; Liu Y; Xue H; Li J; Zhang Z; Xu Q
Oncogene; 2023 Jan; 42(2):99-112. PubMed ID: 36376513
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of ephrinB2 in periodontal ligament stem cells (PDLSCs) modulates osteogenic differentiation via signaling crosstalk between ephrinB2 and EphB4 in PDLSCs and between PDLSCs and pre-osteoblasts within co-culture.
Zhu SY; Wang PL; Liao CS; Yang YQ; Yuan CY; Wang S; Dissanayaka WL; Heng BC; Zhang CF
J Periodontal Res; 2017 Jun; 52(3):562-573. PubMed ID: 27763659
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
8. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of Eph receptor B1 and ephrin B2 in port-wine stain endothelial progenitor cells contributes to clinicopathological vasculature dilatation.
Tan W; Wang J; Zhou F; Gao L; Yin R; Liu H; Sukanthanag A; Wang G; Mihm MC; Chen DB; Nelson JS
Br J Dermatol; 2017 Dec; 177(6):1601-1611. PubMed ID: 28599054
[TBL] [Abstract][Full Text] [Related]
11. Upregulated EFNB2 and EPHB4 promotes lung development in a nitrofen-induced congenital diaphragmatic hernia rat model.
Liu H; Li X; Yu WQ; Liu CX
Int J Mol Med; 2018 Nov; 42(5):2373-2382. PubMed ID: 30106123
[TBL] [Abstract][Full Text] [Related]
12. Role of EFNB2/EPHB4 signaling in spiral artery development during pregnancy: An appraisal.
Dong H; Yu C; Mu J; Zhang J; Lin W
Mol Reprod Dev; 2016 Jan; 83(1):12-8. PubMed ID: 26501487
[TBL] [Abstract][Full Text] [Related]
13. Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
Teng L; Nakada M; Furuyama N; Sabit H; Furuta T; Hayashi Y; Takino T; Dong Y; Sato H; Sai Y; Miyamoto K; Berens ME; Zhao SG; Hamada J
Neuro Oncol; 2013 Dec; 15(12):1710-20. PubMed ID: 24121831
[TBL] [Abstract][Full Text] [Related]
14. A synthetic bivalent peptide ligand of EphB4 with potent agonistic activity.
Fan T; Liang B; Nie L; Wang J; Zhang H; Ciechanover A; Xu Y; An J; Huang Z
Eur J Med Chem; 2022 Dec; 244():114804. PubMed ID: 36208510
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of
Ni Q; Chen P; Zhu B; Li J; Xie D; Ma X
Oncol Lett; 2020 Jan; 19(1):917-929. PubMed ID: 31885720
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes occur in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice.
Zhang J; Dong H; Wang B; Zhu S; Croy BA
Biol Reprod; 2008 Sep; 79(3):450-8. PubMed ID: 18463357
[TBL] [Abstract][Full Text] [Related]
17. Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear.
Raft S; Andrade LR; Shao D; Akiyama H; Henkemeyer M; Wu DK
Dev Biol; 2014 Jun; 390(1):51-67. PubMed ID: 24583262
[TBL] [Abstract][Full Text] [Related]
18. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
19. Ephrin-B2 inhibits Aβ
Zhong S; Pei D; Shi L; Cui Y; Hong Z
Neurosci Lett; 2019 Jun; 704():50-56. PubMed ID: 30936033
[TBL] [Abstract][Full Text] [Related]
20. DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.
Alam SK; Yadav VK; Bajaj S; Datta A; Dutta SK; Bhattacharyya M; Bhattacharya S; Debnath S; Roy S; Boardman LA; Smyrk TC; Molina JR; Chakrabarti S; Chowdhury S; Mukhopadhyay D; Roychoudhury S
Cell Death Differ; 2016 Apr; 23(4):707-22. PubMed ID: 26494468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
